Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) on Tuesday, plunged -4.60% from the previous trading day, before settling in for the closing price of $6.52. Within the past 52 weeks, IRWD’s price has moved between $5.47 and $15.70.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has jumped its sales by 5.56% annually for the last half of the decade. The company achieved an average annual earnings per share of 106.82%. With a float of $154.79 million, this company’s outstanding shares have now reached $156.35 million.
In an organization with 267 employees, it is important to assess its efficiency.
Ironwood Pharmaceuticals Inc (IRWD) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Ironwood Pharmaceuticals Inc is 2.62%, while institutional ownership is 109.97%. The most recent insider transaction that took place on Jun 10 ’24, was worth 143,198. In this transaction Director of this company sold 22,766 shares at a rate of $6.29, taking the stock ownership to the 139,528 shares. Before that another transaction happened on Jun 07 ’24, when Company’s Director sold 35,574 for $6.61, making the entire transaction worth $235,144. This insider now owns 48,633 shares in total.
Ironwood Pharmaceuticals Inc (IRWD) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 106.82% per share during the next fiscal year.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Trading Performance Indicators
Ironwood Pharmaceuticals Inc (IRWD) is currently performing well based on its current performance indicators. A quick ratio of 0.82 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.39. Likewise, its price to free cash flow for the trailing twelve months is 6.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -6.79, a number that is poised to hit 0.16 in the next quarter and is forecasted to reach 0.74 in one year’s time.
Technical Analysis of Ironwood Pharmaceuticals Inc (IRWD)
Let’s dig in a bit further. During the last 5-days, its volume was 2.07 million. That was inferior than the volume of 3.79 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 81.29%. Additionally, its Average True Range was 0.33.
During the past 100 days, Ironwood Pharmaceuticals Inc’s (IRWD) raw stochastic average was set at 7.33%, which indicates a significant decrease from 61.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.87% in the past 14 days, which was lower than the 92.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $6.77, while its 200-day Moving Average is $9.62. However, in the short run, Ironwood Pharmaceuticals Inc’s stock first resistance to watch stands at $6.43. Second resistance stands at $6.65. The third major resistance level sits at $6.76. If the price goes on to break the first support level at $6.11, it is likely to go to the next support level at $6.00. The third support level lies at $5.79 if the price breaches the second support level.
Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) Key Stats
Market capitalization of the company is 988.73 million based on 156,529K outstanding shares. Right now, sales total 442,740 K and income totals -1,002 M. The company made 74,880 K in profit during its latest quarter, and -4,160 K in sales during its previous quarter.
